Benzinga's Top Upgrades

Analysts at Leerink Swann upgraded Cubist Pharmaceuticals CBST from “market perform” to “outperform.” The target price for Cubist Pharmaceuticals has been raised from $57 to $76. Cubist's shares closed at $65.68 yesterday. Analysts at Berenberg upgraded Applied Materials AMAT from “hold” to “buy.” Applied Materials' shares closed at $17.84 yesterday. Stifel Nicolaus upgraded Fabrinet FN from “hold” to “buy.” The target price for Fabrinet is set to $20. Fabrinet's shares closed at $14.79 yesterday. Analysts at Wells Fargo upgraded Occidental Petroleum OXY from “market perform” to “outperform.” Occidental Petroleum's shares closed at $92.91 yesterday.